New Vaccination Recommendations for COVID-19, Flu, and RSV as Fall Approaches
RALEIGH, N.C. (WTVD) — As the fall season approaches, health officials are urging the public to be prepared for the seasonal illnesses that typically come with it. This year, the Centers for Disease Control and Prevention (CDC) has made some slight changes to its recommendations for vaccinations related to COVID-19, flu, and respiratory syncytial virus (RSV).
COVID-19 remains a concern despite the downward trend in metrics since January. Dr. David Weber, the medical director of UNC’s Department of Infection Prevention, emphasized that the virus is still present and could potentially develop into a new variant that is even more deadly. He expects that in the next year, COVID-19 will rival RSV and the flu in terms of hospitalizations and deaths.
In North Carolina, there has been an average of 159 COVID-19-related hospitalizations per week since May. Nationwide, the XBB strains of the virus account for the majority of new cases. As a result, federal officials recently voted to tweak the COVID-19 vaccine to specifically target XBB variants. The hope is that this modification will encourage more people to get a booster shot. Currently, only one out of five North Carolinians who received the first round of vaccinations have received a second booster.
Dr. Thomas Holland, an associate professor of medicine at Duke University, explained that the new COVID-19 vaccine is expected to be available in September. He believes that it will eventually become a single shot administered once a year, similar to the flu shot.
As for the flu, last year’s season arrived earlier than usual. However, there is no guarantee that the same trend will occur this year. To stay protected, doctors advise getting the flu shot as soon as it becomes available in September or October. Pregnant individuals in their third trimester and children who will not have an opportunity to return to the doctor in the fall can receive the shot earlier.
Vaccination for respiratory syncytial virus (RSV) is also important, especially for individuals with underlying lung or heart diseases. Currently, RSV vaccines are expected to be geared towards adults aged 60 and older.
Dr. Holland emphasized that all three vaccines have been approved because they are effective and life-saving. Increased uptake of these vaccines will not only protect individuals but also benefit the community as a whole.
While waiting for the vaccines to become available, doctors recommend practicing good hygiene and taking preventive measures. Anyone feeling sick should stay home, and wearing a mask in public with symptoms is advised.
As fall approaches, it is crucial to prioritize vaccinations to minimize the impact of these seasonal illnesses. By following recommended guidelines and staying informed, individuals can protect themselves and their communities from the potential risks associated with COVID-19, flu, and RSV.